← Back to Search

cMAP Flow V 2.0 for Sleep Apnea

N/A
Waitlist Available
Led By Debra Morrison, M.D.
Research Sponsored by NovaResp Technologies Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be a current PAP machine user.
No history of self-reported cardiovascular or neurological issues
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 nights (approx. 8hrs/night)
Awards & highlights

Study Summary

This study is evaluating whether a machine that can predict apnea events can prevent them.

Eligible Conditions
  • Sleep Apnea

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 nights (approx. 8hrs/night)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 nights (approx. 8hrs/night) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy to prevent the occurrence of obstructive sleep apnea.
Secondary outcome measures
Intervention treatment changes quality of sleep.
Intervention treatment has an effect on patient adherence

Trial Design

2Treatment groups
Experimental Treatment
Group I: Intervention-firstExperimental Treatment1 Intervention
Participants in this arm will receive the Intervention treatment on the first night, and the control treatment on the second night.
Group II: Control-firstExperimental Treatment1 Intervention
Participants in this arm will receive the Control treatment on the first night, and the Intervention treatment on the second night.

Find a Location

Who is running the clinical trial?

NovaResp Technologies IncLead Sponsor
3 Previous Clinical Trials
260 Total Patients Enrolled
2 Trials studying Sleep Apnea
60 Patients Enrolled for Sleep Apnea
Debra Morrison, M.D.Principal InvestigatorNova Scotia Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025